| 3.84 Data as of 4:00pm ET |  +0.12 / +3.23%Today’s Change | 1.17 Today|||52-Week Range 3.96 | +217.36% Year-to-Date |
| Previous close | 3.72 |
| Today’s open | 3.79 |
| Day’s range | 3.76 - 3.96 |
| Volume | 629,344 |
| Average volume (3 months) | 123,714 |
| Market cap | $86.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -170.45% |
| Earnings growth (this year) | +63.90% |
| Earnings growth (next 5 years) | +0.00% |
| Revenue growth (last year) | -28.98% |
| P/E ratio | NM |
| Price/Sales | 13.62 |
| Price/Book | 5.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| AGENAgenus Inc | +0.03 | +0.80% |
| BCRXBioCryst Pharmaceuti... | +0.09 | +5.29% |
| PIPPharmAthene Inc | +0.01 | +0.64% |
| CURNeuralstem Inc | -0.03 | -2.11% |
| Next reporting date | September 23, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $3.5M |
| Annual profit (last year) | -$24.8M |
| Net profit margin | -704.34% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Paul Ashton, PhD |
Vice President- Operations Marty Nazzaro |
Corporate headquarters Waterson, Massachusetts |
.
